We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
Trades about 46% below its sector, cheaper than its peers on earnings.
Huapont Life Sciences Co., Ltd. is a multifaceted company engaged in both the pharmaceutical and agrochemical industries, with operations spanning China and international markets. Its pharmaceutical arm is dedicated to the manufacture and distribution of medicinal preparations and their precursors. The company offers a broad range of healthcare products, including treatments for skin conditions, tuberculosis, infections, respiratory issues, cancer, and eye ailments, in addition to general wellness products. Within its agrochemical division, Huapont supplies technical pesticides, intermediates, and finished products, alongside providing technical services for GLP registration. Founded in 2001 and based in Chongqing, China, the company adopted its current name, Huapont Life Sciences Co., Ltd., in September 2015, having previously been known as Huapont-Nutrichem Co., Ltd. It was formerly a subsidiary of Huipont Tourism Co. Ltd.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save 002004.SZ and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
